Waymo to double down on winter testing its robotaxis

Trending Companies

Avoli, a company that designs and manufactures volleyball footwear, gear, and equipment exclusively for women and girl athletes, raises $2.1MM Seed from Shane Stent.

Volley Ball • Portland, OR • Post-Money Valuation

3V Infrastructure, a company that operates an electric vehicle charging (EV) infrastructure investor company, raises $40MM Equity Funding from Greenbacker Labs.

Electric Vehicle • New York, NY • Post-Money Valuation

Cala Systems, a company that designs, manufactures, and sells the world's first intelligent heat pump water heater, raises $5.6MM Seed from Massachusetts Clean Energy Center.

Pumps • Somerville, MA • Post-Money Valuation

IDRx, a company that develops oncology-based precision therapies intended to revolutionize the treatment of cancer, raises $120MM Series B from RA Capital Management.

Therapeutics • Plymouth, MA • Post-Money Valuation

H3X Technologies, a company that manufactures aviation-grade electric propulsion systems, raises $20MM Series A from Infinite Capital.

Aviation • Louisville, CO • Post-Money Valuation

Growlink, a company that develops environment controls, irrigation controls, hardware and software products for the agriculture sector, raises $2MM Seed from Casa Verde Capital.

AgTech • Denver, CO • Post-Money Valuation

CloudPay, a company that provides global payroll, treasury, and on-demand pay solutions to multinational organizations, raises $120MM Equity Funding from Blue Owl Capital.

Payroll • Raleigh, NC • Post-Money Valuation

SYSO Technologies, a company that develops a renewable energy and storage asset management platform, raises $14.5MM Series B from Kimmeridge.

Renewable Energy • Boston, MA • Post-Money Valuation

Neon, a company that develops open-source cloud-native Postgres, raises $25.6MM Equity Funding from Microsoft Ventures.

Developer Tools • San Francisco, CA • Post-Money Valuation

Interius, a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas, raises $67MM Equity Funding from Cormorant Asset Management.

Biopharmaceuticals • Philadelphia, PA • Post-Money Valuation